CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
that suggests the potential for clinical benefit of COVID-19 patients.1. Treat Infection of Multiple Gene Mutation COVID-19...
Early Phase 1
North Bethesda, Maryland, United States
COVID-19 is a systemic inflammatory disease involving many organs including the lungs, vascular system liver and myocardium that le-...
Baltimore, Maryland, United States
mild to severe acute respiratory distress syndrome (ARDS) due to COVID-19 resultant from 2019-nCoV coronavirus infection, or result...
Phase 1
Baltimore, Maryland, United States and 2 other locations
Performance of the LumiraDx SARS-CoV-2 Ag assay will be assessed by comparison to a reference method.
Millersville, Maryland, United States and 6 other locations
a completed primary series and bivalent booster of mRNA based COVID-19 vaccine and have =\<2500 U/mL SARS-CoV-2 S antibody concentr...
Phase 2
Baltimore, Maryland, United States and 5 other locations
This study is an adaptive, randomized, double blind, platform trial evaluating promising investigational products (IP) for safety and efficacy as ear...
Phase 2
Baltimore, Maryland, United States and 5 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Baltimore, Maryland, United States and 66 other locations
(SARS-CoV2) vaccine tablet VXA-CoV2-3.1 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID...
Phase 2
Baltimore, Maryland, United States and 144 other locations
known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...
Phase 2, Phase 3
Baltimore, Maryland, United States and 214 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 2, Phase 3
Baltimore, Maryland, United States and 114 other locations
Clinical trials
Research sites
Resources
Legal